Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sabrina Zippel"'
Autor:
Sabrina Zippel, Nadine Dilger, Chandralekha Chatterjee, Annamarija Raic, Gerald Brenner-Weiß, Patrik Schadzek, Bastian E Rapp, Cornelia Lee-Thedieck
Publikováno v:
Biofabrication, 14 (3), Art.Nr. 035011
Leukemia patients undergo chemotherapy to combat the leukemic cells (LCs) in the bone marrow. During therapy not only the LCs, but also the blood-producing hematopoietic stem and progenitor cells (HSPCs) may be destroyed. Chemotherapeutics targeting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b421ee12436800ce24ff3763c8fd2dd
https://publikationen.bibliothek.kit.edu/1000148794/149034463
https://publikationen.bibliothek.kit.edu/1000148794/149034463
Autor:
Sabrina, Zippel, Nadine, Dilger, Chandralekha, Chatterjee, Annamarija, Raic, Gerald, Brenner-Weiß, Patrik, Schadzek, Bastian E, Rapp, Cornelia, Lee-Thedieck
Publikováno v:
Biofabrication. 14(3)
Leukemia patients undergo chemotherapy to combat the leukemic cells (LCs) in the bone marrow. During therapy not only the LCs, but also the blood-producing hematopoietic stem and progenitor cells (HSPCs) may be destroyed. Chemotherapeutics targeting
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2017
In leukemia, leukemic cells hijack the hematopoietic stem cell (HSC) microenvironment in the bone marrow-the so-called stem cell niche-by flooding the niche with clonal progeny of leukemic cells. They can exploit signaling pathways which are critical
Publikováno v:
Stem Cell Mobilization ISBN: 9781493995738
In leukemia, leukemic cells hijack the hematopoietic stem cell (HSC) microenvironment in the bone marrow-the so-called stem cell niche-by flooding the niche with clonal progeny of leukemic cells. They can exploit signaling pathways which are critical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ba8d7dee523febe023045abada55cfc
https://doi.org/10.1007/978-1-4939-9574-5_8
https://doi.org/10.1007/978-1-4939-9574-5_8
Autor:
Angela Herman, Sima T. Bhatt, Darlene Monlish, Sabrina Zippel, Laura G. Schuettpelz, Molly Romine
Publikováno v:
Blood Cancer Journal
Toll-like receptor 2 (TLR2) is a member of the TLR family of receptors that play a central role in innate immunity. In addition to regulating effector immune cells, where it recognizes a wide variety of pathogen-associated and nonpathogen-associated